| 2.2 |
6.5 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.6 |
4.8 |
GO:0045360 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 1.2 |
3.7 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.1 |
1.1 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 1.0 |
8.7 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.9 |
3.7 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
| 0.9 |
6.2 |
GO:0002786 |
regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 0.9 |
4.3 |
GO:1903284 |
negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.7 |
4.2 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.7 |
3.4 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.5 |
1.6 |
GO:2000625 |
regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 0.5 |
3.2 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.5 |
1.6 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.5 |
1.6 |
GO:1904235 |
regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.5 |
1.5 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.5 |
2.5 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.5 |
1.5 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.5 |
1.9 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.5 |
0.5 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 0.4 |
0.9 |
GO:0006734 |
NADH metabolic process(GO:0006734) |
| 0.4 |
1.3 |
GO:0070458 |
cellular detoxification of nitrogen compound(GO:0070458) |
| 0.4 |
0.4 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.4 |
0.9 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.4 |
1.7 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.4 |
1.2 |
GO:1990709 |
presynaptic active zone organization(GO:1990709) |
| 0.4 |
1.2 |
GO:0002731 |
negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.4 |
0.4 |
GO:0061341 |
non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.4 |
1.1 |
GO:0035603 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.4 |
1.1 |
GO:1905026 |
regulation of heart looping(GO:1901207) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 0.4 |
2.3 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.4 |
1.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.4 |
0.8 |
GO:0071422 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.4 |
1.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.4 |
1.1 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.4 |
1.1 |
GO:1904317 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.4 |
1.8 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.4 |
2.5 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.4 |
1.1 |
GO:0014876 |
response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.4 |
1.1 |
GO:2001226 |
negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
| 0.4 |
2.1 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.4 |
0.4 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.4 |
1.1 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.4 |
3.2 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.3 |
0.7 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.3 |
4.2 |
GO:0070487 |
monocyte aggregation(GO:0070487) |
| 0.3 |
0.3 |
GO:0071499 |
cellular response to laminar fluid shear stress(GO:0071499) |
| 0.3 |
1.0 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.3 |
0.3 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.3 |
1.0 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.3 |
2.3 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.3 |
1.7 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.3 |
0.7 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.3 |
4.9 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.3 |
1.3 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.3 |
1.0 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.3 |
0.9 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.3 |
3.2 |
GO:0042904 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.3 |
11.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.3 |
1.9 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.3 |
1.6 |
GO:1903464 |
negative regulation of mitotic cell cycle DNA replication(GO:1903464) |
| 0.3 |
1.2 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.3 |
1.2 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.3 |
0.3 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.3 |
0.9 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.3 |
0.6 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
0.9 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 |
0.9 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.3 |
2.3 |
GO:0051852 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.3 |
1.2 |
GO:0086092 |
regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.3 |
2.0 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.3 |
0.6 |
GO:2000412 |
positive regulation of thymocyte migration(GO:2000412) |
| 0.3 |
0.9 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.3 |
1.4 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.3 |
1.1 |
GO:0072248 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.3 |
0.8 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.3 |
0.8 |
GO:0002835 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.3 |
0.8 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.3 |
0.8 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.3 |
0.8 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.3 |
1.6 |
GO:1904222 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.3 |
3.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.3 |
1.1 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.3 |
3.0 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.3 |
2.9 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.3 |
0.8 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.3 |
1.1 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.3 |
0.5 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.3 |
1.0 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.3 |
1.0 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 |
1.3 |
GO:0015688 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.3 |
0.3 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.3 |
1.3 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.3 |
1.5 |
GO:0019418 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.3 |
4.3 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.3 |
0.8 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 |
1.3 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.3 |
1.0 |
GO:0090301 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.2 |
2.5 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 |
1.5 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.2 |
0.7 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.2 |
7.4 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.2 |
2.5 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 |
6.8 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.2 |
0.7 |
GO:0072616 |
interleukin-18 secretion(GO:0072616) |
| 0.2 |
1.0 |
GO:1903116 |
positive regulation of actin filament-based movement(GO:1903116) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.2 |
0.7 |
GO:0070460 |
thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.2 |
1.7 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.2 |
0.2 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.2 |
0.7 |
GO:2000502 |
negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.2 |
0.2 |
GO:0070900 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.2 |
1.2 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.2 |
0.9 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.2 |
0.2 |
GO:0009441 |
glycolate metabolic process(GO:0009441) |
| 0.2 |
0.7 |
GO:2000407 |
CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.2 |
0.7 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.2 |
0.9 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.2 |
1.1 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.2 |
0.9 |
GO:1903778 |
protein localization to vacuolar membrane(GO:1903778) |
| 0.2 |
8.4 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.2 |
0.7 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.2 |
0.7 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.2 |
1.5 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 |
2.2 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.2 |
1.7 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 |
1.1 |
GO:0044856 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.2 |
0.6 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.2 |
1.5 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.2 |
3.0 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 |
0.8 |
GO:2000434 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.2 |
0.2 |
GO:0035284 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.2 |
1.6 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.2 |
0.6 |
GO:0034085 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
2.2 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.2 |
0.8 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.2 |
1.0 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.2 |
14.4 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 |
0.6 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.2 |
1.4 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.2 |
0.8 |
GO:0002503 |
peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.2 |
0.8 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.2 |
0.4 |
GO:0006941 |
striated muscle contraction(GO:0006941) |
| 0.2 |
0.6 |
GO:0003147 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.2 |
0.8 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 |
0.6 |
GO:0034226 |
lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 0.2 |
0.6 |
GO:1903033 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.2 |
0.6 |
GO:0006711 |
estrogen catabolic process(GO:0006711) |
| 0.2 |
0.6 |
GO:0072011 |
glomerular endothelium development(GO:0072011) |
| 0.2 |
7.6 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.2 |
0.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.2 |
0.8 |
GO:0097156 |
fasciculation of motor neuron axon(GO:0097156) |
| 0.2 |
0.4 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.2 |
0.7 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.2 |
0.6 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.2 |
0.2 |
GO:0070433 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.2 |
0.9 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.2 |
0.6 |
GO:0009838 |
abscission(GO:0009838) mitotic cytokinesis checkpoint(GO:0044878) |
| 0.2 |
0.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.2 |
0.6 |
GO:0019836 |
hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.2 |
0.2 |
GO:0051150 |
regulation of smooth muscle cell differentiation(GO:0051150) negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
1.1 |
GO:0043126 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.2 |
1.6 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.2 |
0.7 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.2 |
0.5 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.2 |
1.3 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.2 |
2.0 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 |
0.4 |
GO:1902728 |
positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.2 |
0.2 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.2 |
1.1 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.2 |
0.4 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.2 |
0.5 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.2 |
0.7 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.2 |
0.2 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.2 |
0.7 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.2 |
3.0 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.2 |
2.6 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
1.7 |
GO:0061209 |
cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.2 |
1.4 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.2 |
0.7 |
GO:1905225 |
response to thyrotropin-releasing hormone(GO:1905225) |
| 0.2 |
0.5 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.2 |
2.2 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.2 |
0.9 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.2 |
0.2 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.2 |
0.8 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
1.7 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.2 |
1.3 |
GO:0033216 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 |
0.8 |
GO:0003180 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 0.2 |
1.7 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.2 |
0.7 |
GO:0046850 |
regulation of bone resorption(GO:0045124) regulation of bone remodeling(GO:0046850) |
| 0.2 |
1.0 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.2 |
0.5 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.2 |
1.3 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.2 |
0.5 |
GO:0072069 |
DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.2 |
1.5 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.2 |
0.3 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.2 |
0.8 |
GO:2000551 |
regulation of T-helper 2 cell cytokine production(GO:2000551) |
| 0.2 |
0.2 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.2 |
1.8 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.2 |
4.1 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.2 |
1.6 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.2 |
0.2 |
GO:2000296 |
negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.2 |
0.5 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.2 |
2.1 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.2 |
0.5 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
0.8 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
0.6 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.2 |
0.8 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.2 |
0.9 |
GO:0030581 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.2 |
1.4 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.2 |
0.9 |
GO:0055011 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.2 |
0.8 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.2 |
4.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 |
0.5 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.2 |
0.8 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.2 |
0.8 |
GO:0002826 |
negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.2 |
0.2 |
GO:0046439 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.2 |
1.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.3 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
0.4 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 |
2.4 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
0.9 |
GO:0039689 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
0.6 |
GO:0035482 |
gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.1 |
1.0 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 |
0.4 |
GO:0045726 |
positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.1 |
0.7 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.1 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 0.1 |
0.1 |
GO:1901529 |
positive regulation of anion channel activity(GO:1901529) |
| 0.1 |
0.4 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.1 |
0.4 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.1 |
0.7 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 |
1.6 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.1 |
0.4 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.1 |
0.1 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.3 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.1 |
0.4 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 |
0.4 |
GO:0060730 |
regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.1 |
1.5 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.4 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 0.1 |
0.4 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.1 |
0.6 |
GO:0010983 |
positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.1 |
0.1 |
GO:0032768 |
regulation of monooxygenase activity(GO:0032768) |
| 0.1 |
0.8 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
0.4 |
GO:0061727 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 |
0.3 |
GO:0048754 |
branching morphogenesis of an epithelial tube(GO:0048754) |
| 0.1 |
0.3 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
21.7 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.3 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.1 |
0.3 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.1 |
0.7 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.1 |
0.4 |
GO:0036060 |
filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.1 |
1.8 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
8.9 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.5 |
GO:0060686 |
negative regulation of prostatic bud formation(GO:0060686) |
| 0.1 |
4.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.4 |
GO:0090191 |
negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.1 |
1.5 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.1 |
0.4 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.1 |
1.7 |
GO:2000680 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
0.4 |
GO:0046963 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.1 |
1.0 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.1 |
1.8 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 |
0.3 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.1 |
0.4 |
GO:0070444 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
0.4 |
GO:0031650 |
regulation of heat generation(GO:0031650) |
| 0.1 |
0.6 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.1 |
0.1 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 |
0.8 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.1 |
1.3 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.4 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 |
0.5 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.1 |
0.1 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 |
0.2 |
GO:0001970 |
positive regulation of activation of membrane attack complex(GO:0001970) |
| 0.1 |
1.1 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.1 |
0.4 |
GO:0021912 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 0.1 |
3.3 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.9 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.1 |
0.4 |
GO:0032479 |
regulation of type I interferon production(GO:0032479) |
| 0.1 |
0.1 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.1 |
1.3 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.1 |
0.6 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.5 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.1 |
0.8 |
GO:0030450 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.1 |
1.7 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.4 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.1 |
0.1 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.1 |
1.5 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
1.7 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
| 0.1 |
0.4 |
GO:0002728 |
negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.1 |
0.2 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.1 |
0.1 |
GO:1903365 |
regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 0.1 |
0.5 |
GO:0045077 |
negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
| 0.1 |
0.1 |
GO:0051784 |
negative regulation of mitotic nuclear division(GO:0045839) negative regulation of nuclear division(GO:0051784) |
| 0.1 |
0.5 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.1 |
0.9 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.1 |
0.2 |
GO:0060389 |
pathway-restricted SMAD protein phosphorylation(GO:0060389) |
| 0.1 |
1.5 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.5 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.1 |
0.8 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
0.8 |
GO:0002483 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 0.1 |
0.3 |
GO:0061193 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.1 |
6.3 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.2 |
GO:0003051 |
angiotensin-mediated drinking behavior(GO:0003051) |
| 0.1 |
0.3 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
0.2 |
GO:0060796 |
regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.1 |
0.6 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 |
0.2 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
0.6 |
GO:0030807 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.1 |
0.7 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
0.8 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.1 |
1.6 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
0.7 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
0.2 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.1 |
0.5 |
GO:0009253 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.1 |
1.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 |
0.7 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
0.3 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.1 |
0.6 |
GO:0030421 |
defecation(GO:0030421) |
| 0.1 |
0.5 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
1.5 |
GO:0046051 |
UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
| 0.1 |
0.1 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 |
0.4 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.1 |
0.2 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.1 |
0.2 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.9 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.3 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) |
| 0.1 |
0.3 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
1.9 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 |
0.3 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.1 |
2.3 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.1 |
0.5 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.1 |
1.8 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
0.3 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.1 |
0.2 |
GO:0034971 |
histone H3-R17 methylation(GO:0034971) |
| 0.1 |
1.2 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.1 |
0.3 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.1 |
0.3 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 |
1.2 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.2 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
1.2 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.1 |
0.4 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 |
0.2 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 |
0.4 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 |
0.3 |
GO:0060380 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.1 |
0.2 |
GO:0044029 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 |
0.3 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.1 |
0.5 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
1.1 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
2.2 |
GO:0044364 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 |
0.3 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
0.3 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 |
0.7 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.1 |
0.5 |
GO:0060005 |
vestibular reflex(GO:0060005) |
| 0.1 |
2.5 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
1.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
0.1 |
GO:0051940 |
regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.1 |
1.2 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 |
1.6 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.1 |
0.7 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.5 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.1 |
0.6 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.1 |
0.7 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 0.1 |
1.8 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 |
0.3 |
GO:1904849 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 |
1.4 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.2 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 |
0.4 |
GO:0015819 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
| 0.1 |
0.2 |
GO:0032667 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.1 |
0.2 |
GO:1902714 |
negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.1 |
0.6 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.2 |
GO:0007402 |
ganglion mother cell fate determination(GO:0007402) |
| 0.1 |
0.2 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 |
2.4 |
GO:0001562 |
response to protozoan(GO:0001562) |
| 0.1 |
1.6 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
0.5 |
GO:0061734 |
parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.1 |
0.4 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.4 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
0.3 |
GO:0044467 |
negative regulation of dopamine secretion(GO:0033602) glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.1 |
0.7 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.1 |
1.3 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.4 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.6 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.1 |
0.3 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 |
2.2 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.1 |
0.2 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 |
0.1 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 |
0.6 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
1.7 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.2 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
0.1 |
GO:0035809 |
regulation of urine volume(GO:0035809) |
| 0.1 |
0.5 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
0.1 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.1 |
0.3 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 |
3.3 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.4 |
GO:0070173 |
regulation of enamel mineralization(GO:0070173) |
| 0.1 |
0.6 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.4 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 |
0.3 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.1 |
0.3 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
0.2 |
GO:1904744 |
positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 |
0.2 |
GO:0009804 |
coumarin metabolic process(GO:0009804) |
| 0.1 |
0.7 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.1 |
0.5 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.1 |
0.3 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 |
0.2 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.1 |
0.3 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.1 |
0.7 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.1 |
0.3 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.1 |
8.6 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 |
0.4 |
GO:0032232 |
negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 |
0.8 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.8 |
GO:0060137 |
maternal process involved in parturition(GO:0060137) |
| 0.1 |
0.2 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.1 |
1.0 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
0.7 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
0.2 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 |
0.7 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 |
0.4 |
GO:0009107 |
lipoate metabolic process(GO:0009106) lipoate biosynthetic process(GO:0009107) |
| 0.1 |
0.4 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.1 |
0.8 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.2 |
GO:0044332 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.1 |
0.4 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
0.6 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.1 |
0.3 |
GO:0061047 |
positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.1 |
0.4 |
GO:0048769 |
sarcomerogenesis(GO:0048769) |
| 0.1 |
1.8 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
2.0 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.5 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.9 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.2 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
0.5 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
1.4 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.1 |
0.3 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
0.7 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 |
0.4 |
GO:0045764 |
positive regulation of cellular amino acid metabolic process(GO:0045764) |
| 0.1 |
0.6 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 |
0.8 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
2.5 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.1 |
0.6 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 |
0.3 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
7.9 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.1 |
0.2 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.1 |
0.7 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.5 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
0.2 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.1 |
0.3 |
GO:0021633 |
optic nerve structural organization(GO:0021633) |
| 0.1 |
2.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.6 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
0.2 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 |
1.6 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.1 |
0.2 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
0.2 |
GO:0060426 |
lung vasculature development(GO:0060426) |
| 0.1 |
1.0 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.7 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.1 |
0.4 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
| 0.1 |
1.3 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
0.3 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.1 |
0.4 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.1 |
0.4 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 |
0.4 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.1 |
GO:0001820 |
serotonin secretion(GO:0001820) regulation of serotonin secretion(GO:0014062) |
| 0.1 |
0.1 |
GO:0019883 |
antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.1 |
0.2 |
GO:1903056 |
regulation of melanosome organization(GO:1903056) |
| 0.1 |
0.3 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.6 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.1 |
GO:0021571 |
rhombomere 5 development(GO:0021571) |
| 0.1 |
0.6 |
GO:0031223 |
auditory behavior(GO:0031223) |
| 0.1 |
0.5 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.1 |
0.1 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
0.4 |
GO:1901185 |
negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.1 |
0.2 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 |
0.4 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
0.2 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.1 |
1.0 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.2 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.1 |
0.7 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.9 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.3 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.1 |
0.3 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.3 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.1 |
1.8 |
GO:0044705 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 |
0.2 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
0.3 |
GO:0051583 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) neurotransmitter reuptake(GO:0098810) |
| 0.1 |
0.4 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.4 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.1 |
0.1 |
GO:0060940 |
epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.1 |
0.1 |
GO:0034130 |
toll-like receptor 1 signaling pathway(GO:0034130) |
| 0.1 |
0.5 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.1 |
0.3 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
0.2 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.1 |
0.8 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.1 |
0.4 |
GO:0097210 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
0.5 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.3 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 0.1 |
0.3 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.1 |
0.3 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
1.4 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 |
0.1 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.1 |
0.2 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.1 |
0.1 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.1 |
1.9 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 |
0.2 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.1 |
0.3 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.4 |
GO:0035822 |
meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
| 0.1 |
5.5 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
0.3 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.1 |
GO:0042542 |
response to hydrogen peroxide(GO:0042542) |
| 0.1 |
0.3 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.1 |
GO:0051891 |
positive regulation of cardioblast differentiation(GO:0051891) |
| 0.1 |
0.1 |
GO:2001038 |
regulation of cellular response to drug(GO:2001038) |
| 0.1 |
1.0 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.1 |
1.0 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.1 |
1.1 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.1 |
0.3 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.1 |
0.1 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 |
0.6 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 0.1 |
0.8 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 |
0.4 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.2 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
0.4 |
GO:2000909 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.1 |
0.2 |
GO:0042427 |
serotonin biosynthetic process(GO:0042427) |
| 0.1 |
0.1 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.1 |
0.2 |
GO:1901254 |
modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.1 |
0.4 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.4 |
GO:0099551 |
synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.1 |
0.9 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.2 |
GO:1902224 |
ketone body metabolic process(GO:1902224) |
| 0.1 |
1.2 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
2.2 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.1 |
0.2 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.1 |
0.1 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.1 |
0.5 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.1 |
0.2 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.1 |
0.2 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.1 |
0.4 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.1 |
0.1 |
GO:0014824 |
artery smooth muscle contraction(GO:0014824) |
| 0.1 |
1.8 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.1 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
1.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.4 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 |
0.2 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
1.1 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.7 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.3 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 |
0.2 |
GO:0097477 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.1 |
0.2 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
0.1 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.1 |
2.1 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.1 |
1.5 |
GO:0042036 |
negative regulation of cytokine biosynthetic process(GO:0042036) |
| 0.1 |
2.2 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
1.6 |
GO:0050821 |
protein stabilization(GO:0050821) |
| 0.1 |
0.7 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
0.2 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.1 |
0.2 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
0.5 |
GO:0002821 |
positive regulation of adaptive immune response(GO:0002821) |
| 0.1 |
0.5 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.1 |
0.5 |
GO:0051785 |
positive regulation of mitotic nuclear division(GO:0045840) positive regulation of nuclear division(GO:0051785) |
| 0.1 |
1.2 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 |
1.3 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
0.6 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
0.3 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.3 |
GO:0007598 |
blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 |
0.8 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
0.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.6 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
1.1 |
GO:0033617 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
0.1 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.1 |
0.4 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.1 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.1 |
0.5 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.2 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.1 |
0.5 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.1 |
0.1 |
GO:0045112 |
integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
| 0.1 |
0.6 |
GO:0046449 |
creatinine metabolic process(GO:0046449) |
| 0.1 |
0.2 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.1 |
0.3 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.1 |
1.9 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.6 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.1 |
0.3 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.1 |
0.7 |
GO:0035036 |
cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
| 0.1 |
0.2 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.1 |
0.9 |
GO:0046641 |
positive regulation of alpha-beta T cell proliferation(GO:0046641) |
| 0.1 |
0.6 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.1 |
0.3 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
0.2 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 |
0.2 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 |
0.2 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.3 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.2 |
GO:0036229 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 |
0.4 |
GO:0045686 |
negative regulation of glial cell differentiation(GO:0045686) |
| 0.1 |
0.1 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 |
0.3 |
GO:0001767 |
establishment of lymphocyte polarity(GO:0001767) |
| 0.1 |
0.3 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
1.6 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.2 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.1 |
GO:2000196 |
positive regulation of female gonad development(GO:2000196) |
| 0.0 |
0.1 |
GO:0019098 |
reproductive behavior(GO:0019098) maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 |
0.2 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.0 |
0.7 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.2 |
GO:0019859 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.0 |
0.4 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 |
2.4 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 |
0.6 |
GO:0006637 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.0 |
0.1 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.0 |
0.3 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.0 |
0.1 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.0 |
0.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.0 |
0.5 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
0.3 |
GO:0046066 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine deoxyribonucleotide catabolic process(GO:0009155) purine ribonucleoside diphosphate catabolic process(GO:0009181) dGDP metabolic process(GO:0046066) |
| 0.0 |
0.1 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.0 |
0.1 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 |
0.1 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.0 |
0.6 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 |
5.8 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.0 |
0.3 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.0 |
0.2 |
GO:2000321 |
positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.0 |
0.2 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.0 |
0.4 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.0 |
0.2 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
2.1 |
GO:0015988 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
| 0.0 |
0.2 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.0 |
0.2 |
GO:0048023 |
positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.0 |
0.6 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.2 |
GO:0003070 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.0 |
0.2 |
GO:1904800 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.0 |
1.1 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.6 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.2 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 |
0.1 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.0 |
0.2 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.0 |
0.2 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.0 |
0.2 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.1 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.0 |
0.5 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.0 |
0.4 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 |
0.0 |
GO:1903413 |
cellular response to bile acid(GO:1903413) |
| 0.0 |
0.4 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.6 |
GO:0040036 |
regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.0 |
0.2 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 |
0.6 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 |
0.2 |
GO:0051610 |
serotonin uptake(GO:0051610) |
| 0.0 |
0.1 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.0 |
0.3 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.0 |
0.1 |
GO:0090675 |
intermicrovillar adhesion(GO:0090675) |
| 0.0 |
0.2 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.0 |
0.2 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.0 |
0.3 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.0 |
0.3 |
GO:0086027 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.0 |
0.1 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.0 |
0.2 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.0 |
0.3 |
GO:0045196 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) response to odorant(GO:1990834) |
| 0.0 |
2.1 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 |
0.4 |
GO:0090190 |
positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.0 |
0.1 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.0 |
0.2 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.0 |
0.3 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 |
0.3 |
GO:0006366 |
transcription from RNA polymerase II promoter(GO:0006366) |
| 0.0 |
0.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.0 |
0.1 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.0 |
0.3 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.4 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.0 |
0.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.0 |
1.4 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.1 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.0 |
0.1 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
1.9 |
GO:0009712 |
catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.0 |
0.1 |
GO:0015993 |
L-ascorbic acid transport(GO:0015882) molecular hydrogen transport(GO:0015993) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.0 |
0.3 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.0 |
0.1 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.0 |
0.2 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.0 |
0.1 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.0 |
0.4 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.0 |
0.1 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.0 |
0.2 |
GO:0033383 |
geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.0 |
0.2 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
| 0.0 |
0.1 |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 0.0 |
0.2 |
GO:0002729 |
positive regulation of natural killer cell cytokine production(GO:0002729) |
| 0.0 |
0.5 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.4 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.0 |
0.1 |
GO:1901536 |
negative regulation of DNA demethylation(GO:1901536) |
| 0.0 |
0.1 |
GO:0001759 |
organ induction(GO:0001759) |
| 0.0 |
0.1 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.0 |
0.3 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.0 |
0.4 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.0 |
0.2 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.5 |
GO:0009595 |
detection of biotic stimulus(GO:0009595) |
| 0.0 |
0.2 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.0 |
0.1 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.0 |
0.4 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.0 |
0.2 |
GO:0030168 |
platelet activation(GO:0030168) |
| 0.0 |
0.0 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
| 0.0 |
0.3 |
GO:0007567 |
parturition(GO:0007567) |
| 0.0 |
0.5 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.0 |
0.2 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.0 |
0.2 |
GO:0021779 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 |
0.2 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 |
0.2 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.0 |
0.2 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.0 |
0.1 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 |
0.0 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.0 |
0.1 |
GO:1904404 |
cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.0 |
0.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.4 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.0 |
0.2 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.4 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.0 |
0.4 |
GO:0048247 |
lymphocyte chemotaxis(GO:0048247) |
| 0.0 |
0.3 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.0 |
0.1 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.0 |
0.3 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.5 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.0 |
0.1 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.0 |
0.1 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.0 |
0.3 |
GO:0006565 |
L-serine catabolic process(GO:0006565) |
| 0.0 |
0.3 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.1 |
GO:0009744 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 |
0.1 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
| 0.0 |
0.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 |
0.3 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.5 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.2 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.0 |
0.5 |
GO:0051480 |
regulation of cytosolic calcium ion concentration(GO:0051480) |
| 0.0 |
0.3 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.0 |
1.2 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.2 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.4 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.1 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.0 |
0.4 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
0.2 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.4 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.0 |
0.0 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.6 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.8 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.0 |
0.7 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.0 |
0.1 |
GO:1902744 |
negative regulation of lamellipodium organization(GO:1902744) |
| 0.0 |
0.1 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.0 |
0.4 |
GO:0010470 |
regulation of gastrulation(GO:0010470) |
| 0.0 |
0.7 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 |
0.2 |
GO:0019470 |
4-hydroxyproline catabolic process(GO:0019470) |
| 0.0 |
0.8 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 |
0.3 |
GO:0045187 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 |
0.1 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 |
0.3 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.0 |
0.2 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.4 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 |
0.2 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.0 |
0.2 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.0 |
0.7 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.1 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.0 |
1.6 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.0 |
0.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.1 |
GO:0045471 |
response to ethanol(GO:0045471) |
| 0.0 |
0.0 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.2 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.0 |
0.6 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.0 |
0.1 |
GO:0051904 |
melanosome localization(GO:0032400) establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) pigment granule localization(GO:0051875) pigment granule transport(GO:0051904) establishment of pigment granule localization(GO:0051905) |
| 0.0 |
0.2 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.1 |
GO:0090114 |
COPII-coated vesicle budding(GO:0090114) |
| 0.0 |
0.2 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 |
0.1 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.0 |
0.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.1 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.0 |
0.0 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.0 |
0.2 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.0 |
0.2 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.0 |
0.6 |
GO:0060444 |
branching involved in mammary gland duct morphogenesis(GO:0060444) |
| 0.0 |
0.2 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 |
0.2 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.0 |
0.2 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.7 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
0.5 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.3 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 |
0.3 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.0 |
0.1 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.0 |
0.1 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.4 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.1 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.3 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.0 |
0.7 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.1 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 |
2.0 |
GO:0060337 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 |
0.0 |
GO:0071393 |
cellular response to progesterone stimulus(GO:0071393) |
| 0.0 |
0.4 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 |
0.2 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.0 |
0.4 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.0 |
1.0 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 |
0.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 |
0.1 |
GO:0051198 |
negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.0 |
0.1 |
GO:0048200 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.3 |
GO:0017015 |
regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) |
| 0.0 |
0.3 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.0 |
0.6 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.0 |
0.3 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.6 |
GO:0001755 |
neural crest cell migration(GO:0001755) |
| 0.0 |
0.2 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.1 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.0 |
1.3 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.0 |
0.1 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.2 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.0 |
0.0 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 0.0 |
0.1 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.0 |
0.1 |
GO:0021902 |
forebrain neuron fate commitment(GO:0021877) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 |
0.7 |
GO:0031163 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.1 |
GO:1903421 |
regulation of synaptic vesicle recycling(GO:1903421) |
| 0.0 |
0.1 |
GO:0070256 |
regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.0 |
0.3 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.1 |
GO:0060605 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.0 |
0.0 |
GO:1900111 |
positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.0 |
0.1 |
GO:0090278 |
negative regulation of peptide secretion(GO:0002792) negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
| 0.0 |
0.2 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.0 |
0.1 |
GO:0015874 |
norepinephrine transport(GO:0015874) |
| 0.0 |
0.1 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.0 |
1.1 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.2 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.0 |
0.2 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.1 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.0 |
0.1 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.3 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.1 |
GO:0032735 |
positive regulation of interleukin-12 production(GO:0032735) |
| 0.0 |
0.3 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.0 |
0.3 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.2 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.0 |
0.1 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.0 |
0.1 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.0 |
0.2 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.0 |
0.2 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.0 |
0.1 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.0 |
0.2 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.0 |
0.1 |
GO:0072217 |
negative regulation of metanephros development(GO:0072217) |
| 0.0 |
0.1 |
GO:0003344 |
pericardium morphogenesis(GO:0003344) |
| 0.0 |
0.2 |
GO:0007351 |
blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 |
1.0 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.2 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.0 |
0.2 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.0 |
0.4 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.3 |
GO:0061097 |
regulation of protein tyrosine kinase activity(GO:0061097) |
| 0.0 |
0.1 |
GO:0002517 |
T cell tolerance induction(GO:0002517) |
| 0.0 |
0.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.0 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 |
0.4 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.0 |
0.1 |
GO:0042471 |
ear morphogenesis(GO:0042471) |
| 0.0 |
3.0 |
GO:0042742 |
defense response to bacterium(GO:0042742) |
| 0.0 |
0.1 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.0 |
0.2 |
GO:1903679 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
0.3 |
GO:0060044 |
negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
| 0.0 |
0.2 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.1 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
1.5 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.1 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.0 |
0.0 |
GO:0006522 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.0 |
0.0 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.0 |
0.1 |
GO:0009584 |
detection of visible light(GO:0009584) |
| 0.0 |
0.3 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.1 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.0 |
0.4 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.0 |
0.1 |
GO:0060534 |
Sertoli cell fate commitment(GO:0060010) trachea cartilage development(GO:0060534) |
| 0.0 |
0.5 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.0 |
0.5 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.1 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 |
0.3 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.1 |
GO:0006540 |
glutamate decarboxylation to succinate(GO:0006540) |
| 0.0 |
0.3 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 |
0.0 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.1 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.0 |
0.2 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.2 |
GO:0070197 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.0 |
0.4 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 0.0 |
0.3 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.1 |
GO:0015671 |
gas transport(GO:0015669) oxygen transport(GO:0015671) |
| 0.0 |
0.2 |
GO:0048599 |
oocyte development(GO:0048599) |
| 0.0 |
0.0 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.0 |
0.1 |
GO:0038042 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 0.0 |
0.2 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.3 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.1 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.0 |
0.8 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 |
0.4 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.2 |
GO:0035307 |
positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.0 |
0.3 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.0 |
0.1 |
GO:0046116 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.2 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.1 |
GO:0045987 |
positive regulation of smooth muscle contraction(GO:0045987) |
| 0.0 |
0.0 |
GO:0002761 |
regulation of myeloid leukocyte differentiation(GO:0002761) |
| 0.0 |
0.5 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.0 |
0.1 |
GO:0033572 |
ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
| 0.0 |
0.1 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.1 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.0 |
0.3 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.0 |
0.3 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 |
0.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.1 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.2 |
GO:0051437 |
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 0.0 |
0.2 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.1 |
GO:0010578 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.1 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.0 |
0.5 |
GO:0043304 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 |
0.2 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 |
0.3 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.1 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
| 0.0 |
0.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.1 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.0 |
0.1 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.0 |
0.6 |
GO:0002228 |
natural killer cell mediated immunity(GO:0002228) |
| 0.0 |
0.1 |
GO:0015822 |
mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
| 0.0 |
0.0 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.5 |
GO:0043535 |
regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.0 |
0.1 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 |
0.4 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.0 |
0.1 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.0 |
0.1 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 |
0.1 |
GO:0090042 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.1 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.0 |
0.2 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.0 |
0.1 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.1 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.1 |
GO:0060841 |
venous blood vessel development(GO:0060841) |
| 0.0 |
0.0 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
| 0.0 |
0.3 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.0 |
0.1 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 |
0.1 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.0 |
0.1 |
GO:0015846 |
polyamine transport(GO:0015846) |
| 0.0 |
0.1 |
GO:0050427 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 |
0.1 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.0 |
0.1 |
GO:1901475 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 |
0.0 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.0 |
0.0 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.0 |
0.2 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) |
| 0.0 |
0.1 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.0 |
0.1 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.0 |
0.9 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.1 |
GO:0051282 |
sequestering of calcium ion(GO:0051208) release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) |
| 0.0 |
0.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 |
0.3 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.1 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 |
0.1 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.0 |
2.3 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.2 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.0 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.0 |
0.1 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.0 |
0.1 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.0 |
0.1 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.3 |
GO:0051412 |
response to corticosterone(GO:0051412) |
| 0.0 |
0.1 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.0 |
0.1 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 |
0.1 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.0 |
0.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.1 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.0 |
0.1 |
GO:0043605 |
cellular amide catabolic process(GO:0043605) |
| 0.0 |
0.1 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 |
0.2 |
GO:0090312 |
positive regulation of protein deacetylation(GO:0090312) |
| 0.0 |
0.2 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
0.0 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 0.0 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.1 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
0.4 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.2 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 |
0.2 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.0 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.1 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.0 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.0 |
0.0 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) |
| 0.0 |
0.1 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 |
0.1 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.0 |
0.1 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.0 |
0.1 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.0 |
0.0 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.0 |
0.0 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.0 |
GO:1904383 |
response to sodium phosphate(GO:1904383) |
| 0.0 |
0.2 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 |
0.1 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.0 |
0.2 |
GO:0015986 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.1 |
GO:0060349 |
bone morphogenesis(GO:0060349) |
| 0.0 |
0.2 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.1 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.0 |
0.2 |
GO:0010595 |
positive regulation of endothelial cell migration(GO:0010595) |
| 0.0 |
0.1 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 |
0.0 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.1 |
GO:0046321 |
positive regulation of fatty acid oxidation(GO:0046321) |
| 0.0 |
0.6 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) |
| 0.0 |
0.3 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.0 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
